GFL
NVO

Granite FO LLC’s Novo Nordisk NVO Stock Holding History

Granite FO LLC’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.3K Hold
590
– – 0.02% 85
2026
Q1 		$21.7K Hold
590
– – 0.01% 88
2025
Q4 		$30K Hold
590
– – 0.02% 89
2025
Q3 		$32.7K Hold
590
– – 0.02% 93
2025
Q2 		$40.7K Hold
590
– – 0.02% 90
2025
Q1 		$41K Hold
590
– – 0.02% 87
2024
Q4 		$50.8K Hold
590
– – 0.03% 84
2024
Q3 		$70.3K Buy
+590
New +$78.7K 0.04% 79
2024
Q2 		– Sell
-590
Closed -$79.3K – 150
2024
Q1 		$79.3K Sell
590
-450
-43% -$53.6K 0.05% 76
2023
Q4 		$108K Sell
1,040
-250
-19% -$24.7K 0.07% 71
2023
Q3 		$117K Hold
1,290
– – 0.08% 69
2023
Q2 		$104K Hold
1,290
– – 0.07% 75
2023
Q1 		$108K Hold
1,290
– – 0.07% 114
2022
Q4 		$80.4K Buy
+1,290
New +$75.6K 0.06% 84

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Granite FO LLC's NVO Position: Q2 2026 in Review

Granite FO LLC held its Novo Nordisk (NVO) position steady in Q2 2026 at 590 shares worth $28.3K. The position accounts for 0.02% of the portfolio, ranked #85.

Granite FO LLC first reported a position in NVO in Q4 2022 and has held it in 14 quarters since. The position peaked at $117K in Q3 2023. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Granite FO LLC held 590 shares of Novo Nordisk worth $28.3K as of Q2 2026.
  • Granite FO LLC left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.02% of Granite FO LLC's portfolio in Q2 2026, its #85 holding.
  • Granite FO LLC first reported a position in Novo Nordisk in Q4 2022 and has held it in 14 quarters since.
  • Granite FO LLC's Novo Nordisk position peaked at $117K in Q3 2023.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Granite FO LLC's 13F filing for Q2 2026, filed 15 Jul 2026.